These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10459449)

  • 1. The role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. A pilot experimental study.
    Orvieto R; Abir R; Kaplan B; Bar-Hava I; Ben-Rafael Z
    Clin Exp Obstet Gynecol; 1999; 26(2):98-9. PubMed ID: 10459449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome.
    Orvieto R; Achiron A; Margalit R; Ben-Rafael Z
    J Assist Reprod Genet; 1998 Jan; 15(1):46-9. PubMed ID: 9493066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2002; (2):CD001302. PubMed ID: 12076404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.
    Shoham Z; Weissman A; Barash A; Borenstein R; Schachter M; Insler V
    Fertil Steril; 1994 Jul; 62(1):137-42. PubMed ID: 8005278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C
    Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe case of ovarian hyperstimulation syndrome despite the prophylactic administration of intravenous albumin.
    Orvieto R; Dekel A; Dicker D; Bar-Hava I; Ben-Rafael Z
    Fertil Steril; 1995 Oct; 64(4):860-2. PubMed ID: 7545592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome.
    Aboulghar M; Evers JH; Al-Inany H
    Cochrane Database Syst Rev; 2000; (2):CD001302. PubMed ID: 10796765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyperstimulation syndrome in the rabbit.
    Sahin Y; Kontaş O; Müderris II; Cankurtaran M
    Gynecol Endocrinol; 1997 Aug; 11(4):231-6. PubMed ID: 9272418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary.
    Yarali H; Fleige-Zahradka BG; Yuen BH; McComb PF
    Fertil Steril; 1993 Mar; 59(3):657-61. PubMed ID: 8458471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?
    Lewit N; Kol S; Ronen N; Itskovitz-Eldor J
    Fertil Steril; 1996 Oct; 66(4):654-6. PubMed ID: 8816633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome.
    Youssef MA; Al-Inany HG; Evers JL; Aboulghar M
    Cochrane Database Syst Rev; 2011 Feb; (2):CD001302. PubMed ID: 21328249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pentoxifylline in the prevention of ovarian hyperstimulation syndrome in a rabbit model.
    Serin IS; Ozçelik B; Bekyurek T; Ozturk F; Koc N; Sahin Y
    Gynecol Endocrinol; 2002 Oct; 16(5):355-9. PubMed ID: 12587528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome.
    Isik AZ; Vicdan K
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):208-12. PubMed ID: 11451550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
    Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Yang JH; Chen SU; Ho HN; Yang YS
    Fertil Steril; 1997 Aug; 68(2):287-91. PubMed ID: 9240258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyperstimulation syndrome.
    Costabile L; Unfer V; Manna C; Gerli S; Rossetti D; Di Renzo GC
    Gynecol Obstet Invest; 2000; 50(3):182-5. PubMed ID: 11014951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam.
    Saylan A; Arioz DT; Koken T; Dilek H; Saylan F; Yilmazer M
    Acta Obstet Gynecol Scand; 2010 May; 89(5):692-9. PubMed ID: 20423279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human albumin is effective in prevention of severe OHSS.
    Al-Inany HG
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):878-82. PubMed ID: 11580730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome.
    Chen CD; Chao KH; Yang JH; Chen SU; Ho HN; Yang YS
    Fertil Steril; 2003 Jul; 80(1):86-90. PubMed ID: 12849806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.